IL
Illumina
ILMN·NASDAQSan Diego CAFounded 19987,400 employees
Large CapbiotechPublicOncology
Platform: Sequencing
Market Cap
$22B
All Drugs
7
Clinical Trials
13
Failed / Terminated
2
FDA Approved
0
Stock Price & Catalysts (ILMN)
Loading ILMN stock data...
Drug Pipeline (7 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| ILM-4317 | ILM-4317 | NDA/BLA | 2 | TROP-2 | SCD | ||
| Gozeosocimab | ILM-2100 | Phase 2 | 1 | BCMA | LNNB | ||
| Teravorutinib | ILM-2665 | Phase 2 | 2 | JAK2 | AngelmanALL | ||
| ILM-5680 | ILM-5680 | Phase 2 | 2 | BET | MSGIST | ||
| ILM-2412 | ILM-2412 | Phase 3 | 3 | PLK4 | HS | ||
| Rimainavolisib | ILM-5634 | Phase 2 | 1 | PD-1 | PNH | ||
| Semasacituzumab | ILM-281 | Phase 3 | 2 | Nectin-4 | Celiac |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (15)